Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.50
Bid: 309.00
Ask: 310.50
Change: -8.50 (-2.70%)
Spread: 1.50 (0.485%)
Open: 311.50
High: 312.50
Low: 302.00
Prev. Close: 315.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

4 Jun 2019 17:38

RNS Number : 1401B
Oxford Biomedica PLC
04 June 2019
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biomedica plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Prudential plc group of companies

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

03/06/2019

6. Date on which issuer notified (DD/MM/YYYY):

04/06/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

15.35%

0.00%

15.35%

75,555,880

Position of previous notification (if

applicable)

16.84%

0.00%

16.84%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD GBP0.50

GB00BDFBVT43

11,598,648

15.35%

SUBTOTAL 8. A

11,598,648

15.35%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

SUBTOTAL 8.B.2

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Prudential plc

(Parent Company)

15.35%

0.00%

15.35%

M&G Prudential Limited (wholly owned subsidiary of Prudential plc)

15.35%

0.00%

15.35%

M&G Group Limited

(wholly owned subsidiary of M&G Prudential Limited)

15.35%

0.00%

15.35%

M&G Limited

(wholly owned subsidiary of M&G Group Limited)

15.35%

0.00%

15.35%

M&G Investment

Management Limited

(wholly owned subsidiary of M&G Limited)

15.35%

0.00%

15.35%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

 

 

Place of completion

London, United Kingdom

Date of completion

04th June 2019

 

Contact name:

Stuart Paynter

Contact telephone number:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEAKKLEDDNEFF
Date   Source Headline
11th Dec 20137:00 amRNSCIRCULAR & GENERAL MEETING NOTIFICATION
22nd Nov 201312:38 pmRNSDirector/PDMR Shareholding
19th Nov 20137:00 amRNS£5 million Loan Facility from Lead Shareholder
19th Nov 20137:00 amRNSInterim Management Statement
17th Oct 20137:00 amRNSAgreement to Resume Clinical Trials
19th Sep 20137:00 amRNSDirector/PDMR Shareholding
17th Sep 20131:06 pmRNSBlock Listing Return
12th Sep 201311:18 amRNSOxford BioMedica plc Director's Share Purchase
11th Sep 20131:01 pmRNSOxford BioMedica Wins Significant Funding
6th Sep 20134:40 pmRNSSecond Price Monitoring Extn
6th Sep 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20134:08 pmRNSTR1 Form
29th Aug 20137:00 amRNSInterim Results 2013
28th Aug 20137:00 amRNSUS$1 million Milestone Payment from Pfizer
14th Aug 20131:00 pmRNSAnnounced as Funding Competition Winner
29th Jul 20137:00 amRNSPublication of TroVax Phase II Analyses
23rd Jul 20137:00 amRNSNotice of Interim Results
16th Jul 201311:20 amRNSDirector/PDMR Shareholding
1st Jul 20137:00 amRNSUpdate on Glaucoma-GT
28th Jun 20137:00 amRNSTotal Voting Rights
20th Jun 201311:15 amRNSDirector/PDMR Shareholding
19th Jun 201311:00 amRNSTR-1: Notification of Major Interest in Shares
12th Jun 20137:00 amRNSDirectors' Interests in Share Options
10th Jun 201312:59 pmRNSDirector/PDMR Shareholding
10th Jun 201312:59 pmRNSTR-1: Notification of Major Interest in Shares
10th Jun 20137:00 amRNSDirector's Share Purchase
6th Jun 201311:45 amRNSResult of AGM
6th Jun 20137:00 amRNSChange of Adviser and Broker
6th Jun 20137:00 amRNSManagement and Board change
5th Jun 201310:43 amRNSTR-1: Notification of Major Interest in Shares
3rd Jun 20137:00 amRNSClinical Trial Update
24th May 201310:00 amRNSBLOCK LISTING RETURN
16th May 20137:00 amRNSInterim Management Statement
9th May 20139:00 amRNSUpdate from ARVO 2013
3rd May 20132:00 pmRNSHolding(s) in Company
3rd May 20132:00 pmRNSDirector/PDMR Shareholding
1st May 20137:03 amRNSCollaboration with Novartis
17th Apr 20131:00 pmRNS2012 ANNUAL REPORT & ACCOUNTS & AGM NOTIFICATION
7th Mar 20137:00 amRNSInitiation of PII Collaborative Study for TroVax
27th Feb 20137:00 amRNSPreliminary Results
25th Jan 20134:40 pmRNSSecond Price Monitoring Extn
25th Jan 20134:35 pmRNSPrice Monitoring Extension
23rd Jan 20137:00 amRNSNotice of Preliminary Results
29th Nov 20127:00 amRNSExercise of Option by ImaginAb
28th Nov 20127:00 amRNSBlock Listing Return
20th Nov 20127:00 amRNSOcular Clinical Programme Update
14th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20127:00 amRNSIssue of Key US Patent
10th Oct 20127:00 amRNSUpdate on TroVax (R) Development Strategy
3rd Oct 20127:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.